首页> 外文OA文献 >Hematopoietic Progenitor Cell Harvesting Is Feasible after Treatment with Brentuximab Vedotin in CD30+ Lymphoma Patients Who Received Multiple Prior Lines of Treatment

【2h】

Hematopoietic Progenitor Cell Harvesting Is Feasible after Treatment with Brentuximab Vedotin in CD30+ Lymphoma Patients Who Received Multiple Prior Lines of Treatment

机译：在接受了多个先前治疗的CD30 +淋巴瘤患者中，用布伦妥昔单抗Vedotin治疗后，造血祖细胞的采集是可行的

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Afable Manuel; Caimi Paolo F.; Hosing Chitra; de Lima Marcos; Khouri Issa; William Basem M.; Nieto Yago; Cooper Brenda W.; Anderlini Paolo; Gerson Stanton L.; Lazarus Hillard M.; Champlin Richard; Popat Uday;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The European Medicines Agency Review of Brentuximab Vedotin (Adcetris) for the Treatment of Adult Patients With Relapsed or Refractory CD30+ Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use [J] . Iordanis Gravanis, Kyriaki Tzogani, Paula van Hennik, The oncologist . 2016,第1期

机译：欧洲药物管理局对布伦妥昔单抗Vedotin（Adcetris）进行的治疗成年复发或难治性CD30 +霍奇金淋巴瘤或系统间变性大细胞淋巴瘤的成年患者的综述：人类用药品委员会的科学评估摘要
2. Fatal pancreatitis occurred in a patient with refractory CD30+ anaplastic large cell lymphoma after brentuximab vedotin treatment [J] . Chi-Ching Chen, Su-Peng Yeh Journal of Cancer Research and Practice . 2017,第1期

机译：brentuximab vedotin治疗后难治性CD30 +间变性大细胞淋巴瘤患者发生致命性胰腺炎
3. Brentuximab vedotin in the front-line treatment of patients with CD30+ peripheral t-cell lymphomas: Results of a phase i study [J] . FanaleM.A., HorwitzS.M., Forero-TorresA., Journal of Clinical Oncology . 2014,第28期

机译：Brentuximab vedotin在CD30 +周围性T细胞淋巴瘤患者的一线治疗中：I期研究的结果
4. PROGENITOR CELL TRANSPLANTATION FOR THE TREATMENT OF CANINE B-CELL LYMPHOMA [C] . Steven E. Suter American College of Veterinary Internal Medicine Forum . 2010

机译：祖细胞移植治疗犬B细胞淋巴瘤
5. Beta-Adrenergic Receptor Mediated Transcriptional Dysregulation in Hematopoietic Stem and Progenitor Cells Leads to Bone Marrow Erythroid Suppression in Multiple Myeloma Patients - ex vivo Investigations [D] . Subramaniam, Vimal. 2021

机译：β-肾上腺素能受体介导的造血干细胞和祖细胞中的转录失调导致多发性骨髓瘤患者的骨髓红细胞抑制 - 以外的研究
6. Hematopoietic progenitor cell harvesting is feasible after treatment with Brentuximab vedotin in CD30+ lymphoma patients who received multiple prior lines of treatment [O] . Manuel Afable, Paolo F. Caimi, Chitra Hosing, -1

机译：在接受过多次治疗的CD30 +淋巴瘤患者中用Brentuximab vedotin治疗后可行造血祖细胞的收集
7. The European Medicines Agency Review of Brentuximab Vedotin (Adcetris) for the Treatment of Adult Patients With Relapsed or Refractory CD30+ Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use [O] . Iordanis Gravanis, Kyriaki Tzogani, Paula Hennik, 2015

机译：Brentuximab Vedotin（Adcetris）的欧洲药物局审查用于治疗成人复发或难治性CD30 + Hodgkin淋巴瘤或全身厌备大细胞淋巴瘤的综述：用于人类使用的药品委员会科学评估摘要

Hematopoietic Progenitor Cell Harvesting Is Feasible after Treatment with Brentuximab Vedotin in CD30+ Lymphoma Patients Who Received Multiple Prior Lines of Treatment

著录项

相似文献

相关主题

期刊订阅